Kaur, H., Kala, S., Sood, A., Mridha, A. R., Kakkar, A., Yadav, R., . . . Mishra, D. (2022). Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from its Benign Fibro-osseous Lesions. Head and Neck Pathology, 16(3), 728-737. https://doi.org/10.1007/s12105-022-01434-9
Chicago-referens (17:e uppl.)Kaur, Harpreet, Sunny Kala, Anubhuti Sood, Asit Ranjan Mridha, Aanchal Kakkar, Rahul Yadav, Shashwat Mishra, och Deepika Mishra. "Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from Its Benign Fibro-osseous Lesions." Head and Neck Pathology 16, no. 3 (2022): 728-737. https://doi.org/10.1007/s12105-022-01434-9.
MLA-referens (9:e uppl.)Kaur, Harpreet, et al. "Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from Its Benign Fibro-osseous Lesions." Head and Neck Pathology, vol. 16, no. 3, 2022, pp. 728-737, https://doi.org/10.1007/s12105-022-01434-9.